Lack of Toxicity with Long-term Isavuconazole Use in Patients with Hematologic Malignancy

Adam J. Dipippo; Dimitrios P. Kontoyiannis

doi:10.1093/cid/ciz159

Lack of Toxicity with Long-term Isavuconazole Use in Patients with Hematologic Malignancy

Adam J. Dipippo
, Dimitrios P. Kontoyiannis

Infectious Diseases, Infection Control, and Employee Health

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Prolonged courses of isavuconazole (ISA) are increasingly utilized in immunocompromised patients. Toxicities have been reported with long-term use of the other triazoles. We report the first real-life tolerability data in 50 patients with hematologic malignancy receiving ≥6 months of ISA. ISA was well tolerated in our ill patient population.

Original language	English (US)
Pages (from-to)	1624-1627
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	69
Issue number	9
DOIs	https://doi.org/10.1093/cid/ciz159
State	Published - Oct 15 2019

Keywords

hematologic malignancy
invasive mold infections
isavuconazole
toxicity

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciz159

Cite this

@article{7de1fe16bbba4d2fac35dfde1a4a2ccf,

title = "Lack of Toxicity with Long-term Isavuconazole Use in Patients with Hematologic Malignancy",

abstract = "Prolonged courses of isavuconazole (ISA) are increasingly utilized in immunocompromised patients. Toxicities have been reported with long-term use of the other triazoles. We report the first real-life tolerability data in 50 patients with hematologic malignancy receiving ≥6 months of ISA. ISA was well tolerated in our ill patient population.",

keywords = "hematologic malignancy, invasive mold infections, isavuconazole, toxicity",

author = "Dipippo, \{Adam J.\} and Kontoyiannis, \{Dimitrios P.\}",

year = "2019",

month = oct,

day = "15",

doi = "10.1093/cid/ciz159",

language = "English (US)",

volume = "69",

pages = "1624--1627",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Lack of Toxicity with Long-term Isavuconazole Use in Patients with Hematologic Malignancy

AU - Dipippo, Adam J.

AU - Kontoyiannis, Dimitrios P.

PY - 2019/10/15

Y1 - 2019/10/15

N2 - Prolonged courses of isavuconazole (ISA) are increasingly utilized in immunocompromised patients. Toxicities have been reported with long-term use of the other triazoles. We report the first real-life tolerability data in 50 patients with hematologic malignancy receiving ≥6 months of ISA. ISA was well tolerated in our ill patient population.

AB - Prolonged courses of isavuconazole (ISA) are increasingly utilized in immunocompromised patients. Toxicities have been reported with long-term use of the other triazoles. We report the first real-life tolerability data in 50 patients with hematologic malignancy receiving ≥6 months of ISA. ISA was well tolerated in our ill patient population.

KW - hematologic malignancy

KW - invasive mold infections

KW - isavuconazole

KW - toxicity

UR - https://www.scopus.com/pages/publications/85073184077

UR - https://www.scopus.com/pages/publications/85073184077#tab=citedBy

U2 - 10.1093/cid/ciz159

DO - 10.1093/cid/ciz159

M3 - Article

C2 - 30861066

AN - SCOPUS:85073184077

SN - 1058-4838

VL - 69

SP - 1624

EP - 1627

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 9

ER -

Lack of Toxicity with Long-term Isavuconazole Use in Patients with Hematologic Malignancy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this